This new data indicated that BHRA positivity could potentially be implemented as an omalizumab response predictor and showed the potential for off-label use.
Q&A: Nine percent of chronic urticaria patients see exacerbations with COVID-19 vaccines healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Exacerbations follow COVID-19 vaccination in minority of patients with chronic urticaria healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Hamad Medical Corporation (HMC) has introduced new advanced treatment for several allergic disorders as it aspires to provide first-class service to the population of Qatar in line with international standards.